Cargando…

HLA-G Expression Is an Independent Predictor for Improved Survival in High Grade Ovarian Carcinomas

Aberrant expression of human leukocyte antigens (HLA) class I has prognostic importance in various cancers. Here, we evaluated the prognostic value of classical (A/B/C) and nonclassical (G/E) HLA expression in 169 high grade epithelial ovarian cancer samples and linked that to clinicopathological ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rutten, M. J., Dijk, F., Savci-Heijink, C. D., Buist, M. R., Kenter, G. G., van de Vijver, M. J., Jordanova, E. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058481/ https://www.ncbi.nlm.nih.gov/pubmed/24987709 http://dx.doi.org/10.1155/2014/274584

Ejemplares similares

Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma
por: Mehta, Akash M., et al.
Publicado: (2007)

Prognostic Value of Residual Disease after Interval Debulking Surgery for FIGO Stage IIIC and IV Epithelial Ovarian Cancer
por: Rutten, Marianne J., et al.
Publicado: (2015)

A specific gene expression signature for visceral organ metastasis in breast cancer
por: Savci-Heijink, C. D., et al.
Publicado: (2019)

A novel gene expression signature for bone metastasis in breast carcinomas
por: Savci-Heijink, C. Dilara, et al.
Publicado: (2016)

High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status
por: Veluchamy, John P., et al.
Publicado: (2016)

The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer
por: Popple, A, et al.
Publicado: (2012)

Association between gene expression profile of the primary tumor and chemotherapy response of metastatic breast cancer
por: Savci-Heijink, Cemile Dilara, et al.
Publicado: (2017)

Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases
por: Ferns, Debbie M., et al.
Publicado: (2016)

Epithelial-to-mesenchymal transition status of primary breast carcinomas and its correlation with metastatic behavior
por: Savci-Heijink, C. D., et al.
Publicado: (2019)

HLA-E expression in cervical adenocarcinomas: association with improved long-term survival
por: Spaans, Vivian M, et al.
Publicado: (2012)

Retrospective analysis of metastatic behaviour of breast cancer subtypes
por: Savci-Heijink, C. Dilara, et al.
Publicado: (2015)

Deep learning for automatic Gleason pattern classification for grade group determination of prostate biopsies
por: Lucas, Marit, et al.
Publicado: (2019)

High SLC4A11 expression is an independent predictor for poor overall survival in grade 3/4 serous ovarian cancer
por: Qin, Lianzhi, et al.
Publicado: (2017)

Integrin Subunit beta 8 (ITGB8) Upregulation Is an Independent Predictor of Unfavorable Survival of High-Grade Serous Ovarian Carcinoma Patients
por: He, Jing, et al.
Publicado: (2018)

Confocal laser endomicroscopy for upper tract urothelial carcinoma: validation of the proposed criteria and proposal of a scoring system for real-time tumor grading
por: Freund, J. E., et al.
Publicado: (2019)

PDCD6 is an independent predictor of progression free survival in epithelial ovarian cancer
por: Su, Dan, et al.
Publicado: (2012)

Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area
por: Heeren, A. Marijne, et al.
Publicado: (2015)

A critical assessment of SELDI-TOF-MS for biomarker discovery in serum and tissue of patients with an ovarian mass
por: Wegdam, Wouter, et al.
Publicado: (2012)

Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients
por: Rutten, Iris J.G., et al.
Publicado: (2016)

Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer
por: Brennan, Donal J, et al.
Publicado: (2010)

A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer
por: Vollan, Hans Kristian Moen, et al.
Publicado: (2014)

Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients
por: Zeestraten, E C M, et al.
Publicado: (2014)

HLA-G Dimers in the Prolongation of Kidney Allograft Survival
por: Ezeakile, Maureen, et al.
Publicado: (2014)

Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients
por: Zeestraten, E C M, et al.
Publicado: (2014)

‘DURVIT’: a phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: safety, toxicity and effect on the primary tumour- and lymph node microenvironment
por: Rotman, J., et al.
Publicado: (2018)

Cognitive impairment three months after surgery is an independent predictor of survival time in glioblastoma patients
por: Butterbrod, Elke, et al.
Publicado: (2020)

PROX1 is a predictor of survival for gliomas WHO grade II
por: Elsir, T, et al.
Publicado: (2011)

Fluorescence in situ hybridization in 1 mL of selective urine for the detection of upper tract urothelial carcinoma: a feasibility study
por: Freund, J. E., et al.
Publicado: (2018)

ASPM and microcephalin expression in epithelial ovarian cancer correlates with tumour grade and survival
por: Brüning-Richardson, A, et al.
Publicado: (2011)

The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients
por: West, N P, et al.
Publicado: (2010)

MGL Ligand Expression Is Correlated to Lower Survival and Distant Metastasis in Cervical Squamous Cell and Adenosquamous Carcinoma
por: Sahasrabudhe, Neha M., et al.
Publicado: (2019)

HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers
por: Li, Peilong, et al.
Publicado: (2021)

Multi-colour FISH in oesophageal adenocarcinoma—predictors of prognosis independent of stage and grade
por: Geppert, C-I, et al.
Publicado: (2014)

Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity
por: Gooden, M J M, et al.
Publicado: (2014)

Soluble HLA‐G levels in seminal plasma are associated with HLA‐G 3′UTR genotypes and haplotypes
por: Craenmehr, Moniek H. C., et al.
Publicado: (2019)

Epigenetic changes within the promoter region of the HLA-G gene in ovarian tumors
por: Menendez, Laura, et al.
Publicado: (2008)

High Expression of HLA-G in Ovarian Carcinomatosis: The Role of Interleukin-1β
por: Ullah, Matti, et al.
Publicado: (2019)

Label-Free LC-MS(e) in Tissue and Serum Reveals Protein Networks Underlying Differences between Benign and Malignant Serous Ovarian Tumors
por: Wegdam, Wouter, et al.
Publicado: (2014)

HLA-G Gene Variability Is Associated with Papillary Thyroid Carcinoma Morbidity and the HLA-G Protein Profile
por: Bertol, Bruna C., et al.
Publicado: (2023)

Immune landscape in vulvar cancer-draining lymph nodes indicates distinct immune escape mechanisms in support of metastatic spread and growth
por: Heeren, Anne Marijne, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qq3qi9rp95qcbq2q6339ejs6sg